IL-10–producing T cells suppress immune responses in anergic tuberculosis patients
Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Anne E. Goldfeld(Boston Children's Hospital), Alla Berezovskaya(Ontario Institute for Cancer Research), Jean‐Marc Reynes(Institut Pasteur du Cambodge), Christopher C. Dascher(Brigham and Women's Hospital), Dominique Rousset(Institut Pasteur du Cambodge), Sok Thim(Cambodian Institute for Cooperation and Peace), Julio C. Delgado(Dana-Farber Cancer Institute), Edmond J. Yunis(Dana-Farber Cancer Institute), Eunice Y. Tsai(Dana-Farber/Boston Children's Cancer and Blood Disorders Center)
Cited by 401
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k
Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation
|Science|1993|914
The complex role of tumor-infiltrating macrophages
|Nature Immunology|2022|859